AntiCoagAF
DOAC use in non-valvular AF
#1 Keyword Rankings
Today
Top 10 Rankings
Today
Top 30 Rankings
Today
Top 100 Rankings
Today
Description
This application is for medical practitioners who need to quickly review which anticoagulant (including the direct oral anticoagulants (DOACs)) to use to prevent stroke in patients with non-valvular atrial fibrillation (NVAF).
It contains relevant information about warfarin, apixaban, dabigatran, rivaroxaban and edoxaban.
Topics covered include: comparison of anticoagulants, patient information, when anticoagulation is required, risk-benefit issues, when warfarin is appropriate, how to choose the dose of a DOAC, starting or switching between anticoagulants, edoxban information, clinical monitoring, bleeding risks, use of antiplatelet agents in addition to oral anticoagulants, managing ischemic strokes on DOACs, reversing anticoagulation in the event of intracerebral haemorrhage, a Cookcroft-Gault creatinine clearance calculator and peri-operative management information.
Information contained within the application was edited by Dr Bruce Campbell. Coding was by CereScape (www.cerescape.com). It is our aim to keep this information current, and we welcome constructive comments and evidenced updated information. Any profit generated by this application will be used to fund stroke research.
Hide..
Show more..
It contains relevant information about warfarin, apixaban, dabigatran, rivaroxaban and edoxaban.
Topics covered include: comparison of anticoagulants, patient information, when anticoagulation is required, risk-benefit issues, when warfarin is appropriate, how to choose the dose of a DOAC, starting or switching between anticoagulants, edoxban information, clinical monitoring, bleeding risks, use of antiplatelet agents in addition to oral anticoagulants, managing ischemic strokes on DOACs, reversing anticoagulation in the event of intracerebral haemorrhage, a Cookcroft-Gault creatinine clearance calculator and peri-operative management information.
Information contained within the application was edited by Dr Bruce Campbell. Coding was by CereScape (www.cerescape.com). It is our aim to keep this information current, and we welcome constructive comments and evidenced updated information. Any profit generated by this application will be used to fund stroke research.
Screenshots
User Rating
0 out of 5
0 ratings in Netherlands
Ratings History
Reviews
App doesn't have any reviews yet
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
|
Chart
|
Category
|
Rank
|
|---|---|---|
|
Top Paid
|
|
25
|
|
Top Paid
|
|
299
|
|
Top Paid
|
|
322
|
|
Top Paid
|
|
408
|
|
Top Paid
|
|
434
|
Keywords
Users may also like
| Name | Reviews | Recent release | |
|---|---|---|---|
Stroke Prevention in AFib
|
0
|
1 month ago | |
AF Stroke Risk
Atrial Fibrillation Evaluation
|
0
|
2 years ago | |
Anticoagulation Manager
|
0
|
1 year ago | |
epTools
Resources for Cardiac EP
|
0
|
6 months ago | |
CoaguSafe - Anticoagulant
|
0
|
2 months ago | |
dark GCS
Glasgow Coma Scale
|
0
|
2 years ago | |
CURRENT Dx Tx Otolaryngology
Entire breadth of ENT topics
|
0
|
1 year ago | |
Easy GCS
N/A/
|
0
|
8 years ago | |
Aortic Stenosis Evolut™ TAVI
|
0
|
7 months ago | |
XpressO by MoCA
|
0
|
2 months ago |
Show More
Revenue and Downloads
Gain valuable insights into AntiCoagAF performance with our analytics. Sign up now
to
access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- CereScape Pty Ltd
- Languages
- English
- Recent version
- 1.3 (2 years ago )
- Released on
- Nov 26, 2013 (10 years ago )
- Also available in
- Australia, Netherlands, Greece, Hong Kong, Indonesia, India, South Korea, Mexico, Malaysia, Nigeria, Italy, Norway, New Zealand, Philippines, Romania, Russia, United States, South Africa, Argentina, Spain, Dominican Republic, Brazil, Canada, United Kingdom, Chile, Germany, Colombia, Portugal, Switzerland, Azerbaijan, Saudi Arabia, Sweden, Singapore, Thailand, Taiwan, Ukraine, Austria, Vietnam, Poland, Pakistan, Belarus, China, Czechia, Kazakhstan, Kuwait, Japan, United Arab Emirates, Denmark, Israel, Hungary, France
- Last updated
- 3 days ago